115 related articles for article (PubMed ID: 15069551)
1. Expression of splicing factors in human ovarian cancer.
Fischer DC; Noack K; Runnebaum IB; Watermann DO; Kieback DG; Stamm S; Stickeler E
Oncol Rep; 2004 May; 11(5):1085-90. PubMed ID: 15069551
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
3. Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer.
Scorilas A; Kyriakopoulou L; Katsaros D; Diamandis EP
Br J Cancer; 2001 Jul; 85(2):190-8. PubMed ID: 11461075
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW
Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715
[TBL] [Abstract][Full Text] [Related]
5. Alterations in expression pattern of splicing factors in epithelial ovarian cancer and its clinical impact.
Iborra S; Hirschfeld M; Jaeger M; Zur Hausen A; Braicu I; Sehouli J; Gitsch G; Stickeler E
Int J Gynecol Cancer; 2013 Jul; 23(6):990-6. PubMed ID: 23748175
[TBL] [Abstract][Full Text] [Related]
6. GADD45A is a mediator of CD437 induced apoptosis in ovarian carcinoma cells.
Jiang T; Soprano DR; Soprano KJ
J Cell Physiol; 2007 Sep; 212(3):771-9. PubMed ID: 17474084
[TBL] [Abstract][Full Text] [Related]
7. Intron 9 retention in gene transcripts suggests involvement of CD44 in the tumorigenesis of ovarian cancer.
Stickeler E; Möbus VJ; Kieback DG; Kohlberger P; Runnebaum IB; Kreienberg R
Anticancer Res; 1997; 17(6D):4395-8. PubMed ID: 9494539
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of splicing factor SRp20 mRNA in bipolar disorder patients.
Watanuki T; Funato H; Uchida S; Matsubara T; Kobayashi A; Wakabayashi Y; Otsuki K; Nishida A; Watanabe Y
J Affect Disord; 2008 Sep; 110(1-2):62-9. PubMed ID: 18281098
[TBL] [Abstract][Full Text] [Related]
9. Expression analysis and prognostic significance of the SRA1 gene, in ovarian cancer.
Leoutsakou T; Talieri M; Scorilas A
Biochem Biophys Res Commun; 2006 Jun; 344(2):667-74. PubMed ID: 16631123
[TBL] [Abstract][Full Text] [Related]
10. The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signatures.
Guay D; Evoy AA; Paquet E; Garand C; Bachvarova M; Bachvarov D; Lebel M
Int J Biochem Cell Biol; 2008; 40(11):2492-507. PubMed ID: 18571458
[TBL] [Abstract][Full Text] [Related]
11. Multiple alternative splicing markers for ovarian cancer.
Klinck R; Bramard A; Inkel L; Dufresne-Martin G; Gervais-Bird J; Madden R; Paquet ER; Koh C; Venables JP; Prinos P; Jilaveanu-Pelmus M; Wellinger R; Rancourt C; Chabot B; Abou Elela S
Cancer Res; 2008 Feb; 68(3):657-63. PubMed ID: 18245464
[TBL] [Abstract][Full Text] [Related]
12. High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas.
Benetkiewicz M; Wang Y; Schaner M; Wang P; Mantripragada KK; Buckley PG; Kristensen G; Børresen-Dale AL; Dumanski JP
Genes Chromosomes Cancer; 2005 Mar; 42(3):228-37. PubMed ID: 15578687
[TBL] [Abstract][Full Text] [Related]
13. Expression profiles of mRNA transcript variants encoding the human inhibitor of growth tumor suppressor gene family in normal and neoplastic tissues.
Walzak AA; Veldhoen N; Feng X; Riabowol K; Helbing CC
Exp Cell Res; 2008 Jan; 314(2):273-85. PubMed ID: 17720155
[TBL] [Abstract][Full Text] [Related]
14. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
15. Changes in mRNA and protein levels of human HtrA1, HtrA2 and HtrA3 in ovarian cancer.
Narkiewicz J; Klasa-Mazurkiewicz D; Zurawa-Janicka D; Skorko-Glonek J; Emerich J; Lipinska B
Clin Biochem; 2008 May; 41(7-8):561-9. PubMed ID: 18241672
[TBL] [Abstract][Full Text] [Related]
16. Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma.
Suzuki F; Akahira J; Miura I; Suzuki T; Ito K; Hayashi S; Sasano H; Yaegashi N
Cancer Sci; 2008 Dec; 99(12):2365-72. PubMed ID: 19032364
[TBL] [Abstract][Full Text] [Related]
17. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
Oncol Rep; 2005 Aug; 14(2):449-57. PubMed ID: 16012729
[TBL] [Abstract][Full Text] [Related]
18. ASF/SF2-like maize pre-mRNA splicing factors affect splice site utilization and their transcripts are alternatively spliced.
Gao H; Gordon-Kamm WJ; Lyznik LA
Gene; 2004 Sep; 339():25-37. PubMed ID: 15363843
[TBL] [Abstract][Full Text] [Related]
19. RUNX3 protein is overexpressed in human epithelial ovarian cancer.
Nevadunsky NS; Barbieri JS; Kwong J; Merritt MA; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2009 Feb; 112(2):325-30. PubMed ID: 18937968
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of SR-cyclophilin, an interaction partner of nuclear pinin, releases SR family splicing factors from nuclear speckles.
Lin CL; Leu S; Lu MC; Ouyang P
Biochem Biophys Res Commun; 2004 Aug; 321(3):638-47. PubMed ID: 15358154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
